[Form 3] BALCHEM CORP Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Balchem Corp (BCPC) filed a Form 3 for an officer. The reporting person, identified as the company’s SVP and Chief R&D Officer, reported initial beneficial ownership status as of 10/20/2025 and disclosed no securities are beneficially owned.

The filing was made by one reporting person. An Exhibit 24 Power of Attorney is attached, and the form was signed by an attorney-in-fact.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Graham George

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NJ 07645

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/20/2025

3. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief R&D Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney is attached.

No securities are beneficially owned.

	/s/ Travis Larsen, Attorney in Fact for George Graham	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Balchem (BCPC) disclose in this Form 3?

The officer reported no securities beneficially owned as of 10/20/2025.

Who is the reporting person’s role at Balchem (BCPC)?

The reporting person is the company’s SVP and Chief R&D Officer.

What is the event date for this Form 3?

The event date is 10/20/2025.

Is this a joint filing or by one person?

It is a Form filed by One Reporting Person.

Does the filing include a Power of Attorney?

Yes. Exhibit 24 - Power of Attorney is attached.

Was any derivative or non-derivative ownership reported?

No. The filing states No securities are beneficially owned.

Who signed the Form 3?

It was signed by Travis Larsen as attorney-in-fact for the reporting person.